Cargando…

Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion

The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Zhen, Martin-Garcia, Jose M., Daskalova, Sasha M., Craciunescu, Felicia M., Song, Lusheng, Dörner, Katerina, Hansen, Debra T., Yang, Jay-How, LaBaer, Joshua, Hogue, Brenda G., Mor, Tsafrir S., Fromme, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546420/
https://www.ncbi.nlm.nih.gov/pubmed/26295457
http://dx.doi.org/10.1371/journal.pone.0136507
_version_ 1782386925203619840
author Gong, Zhen
Martin-Garcia, Jose M.
Daskalova, Sasha M.
Craciunescu, Felicia M.
Song, Lusheng
Dörner, Katerina
Hansen, Debra T.
Yang, Jay-How
LaBaer, Joshua
Hogue, Brenda G.
Mor, Tsafrir S.
Fromme, Petra
author_facet Gong, Zhen
Martin-Garcia, Jose M.
Daskalova, Sasha M.
Craciunescu, Felicia M.
Song, Lusheng
Dörner, Katerina
Hansen, Debra T.
Yang, Jay-How
LaBaer, Joshua
Hogue, Brenda G.
Mor, Tsafrir S.
Fromme, Petra
author_sort Gong, Zhen
collection PubMed
description The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662–683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649–705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41.
format Online
Article
Text
id pubmed-4546420
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45464202015-09-01 Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion Gong, Zhen Martin-Garcia, Jose M. Daskalova, Sasha M. Craciunescu, Felicia M. Song, Lusheng Dörner, Katerina Hansen, Debra T. Yang, Jay-How LaBaer, Joshua Hogue, Brenda G. Mor, Tsafrir S. Fromme, Petra PLoS One Research Article The membrane proximal region (MPR, residues 649–683) and transmembrane domain (TMD, residues 684–705) of the gp41 subunit of HIV-1’s envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662–683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649–705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41. Public Library of Science 2015-08-21 /pmc/articles/PMC4546420/ /pubmed/26295457 http://dx.doi.org/10.1371/journal.pone.0136507 Text en © 2015 Gong et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gong, Zhen
Martin-Garcia, Jose M.
Daskalova, Sasha M.
Craciunescu, Felicia M.
Song, Lusheng
Dörner, Katerina
Hansen, Debra T.
Yang, Jay-How
LaBaer, Joshua
Hogue, Brenda G.
Mor, Tsafrir S.
Fromme, Petra
Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title_full Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title_fullStr Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title_full_unstemmed Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title_short Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion
title_sort biophysical characterization of a vaccine candidate against hiv-1: the transmembrane and membrane proximal domains of hiv-1 gp41 as a maltose binding protein fusion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546420/
https://www.ncbi.nlm.nih.gov/pubmed/26295457
http://dx.doi.org/10.1371/journal.pone.0136507
work_keys_str_mv AT gongzhen biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT martingarciajosem biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT daskalovasasham biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT craciunescufeliciam biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT songlusheng biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT dornerkaterina biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT hansendebrat biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT yangjayhow biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT labaerjoshua biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT hoguebrendag biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT mortsafrirs biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion
AT frommepetra biophysicalcharacterizationofavaccinecandidateagainsthiv1thetransmembraneandmembraneproximaldomainsofhiv1gp41asamaltosebindingproteinfusion